| Autor: |
Gambichler, T., Hamdani, N., Budde, H., Sieme, M., Skrygan, M., Scholl, L., Dickel, H., Behle, B., Ganjuur, N., Scheel, C., Abu Rached, N., Ocker, L., Stranzenbach, R., Doerler, M., Pfeiffer, L., Becker, J.C. |
| Předmět: |
|
| Zdroj: |
British Journal of Dermatology; Apr2022, Vol. 186 Issue 4, p728-731, 4p |
| Abstrakt: |
(c, d) Representative immunofluorescence confocal microscopy images of normal skin of a control patient (c) and lesional skin of patient 1 (d) showing spike protein immunoreactivity. These include autoimmune-mediated conditions such as autoimmune blistering diseases (AIBDs), one of which is bullous pemphigoid (BP).1,2 We report new-onset BP in two patients following their first SARS-CoV-2 vaccination. Dear Editor, Growing evidence suggests that SARS-CoV-2 vaccination is associated with a variety of cutaneous reactions. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text